Galectins as potential pharmacological targets in renal injuries of diverse etiology
- 22 May 2020
- journal article
- research article
- Published by Elsevier BV in European Journal of Pharmacology
- Vol. 881, 173213
- https://doi.org/10.1016/j.ejphar.2020.173213
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Serum galectin-9 levels are elevated in the patients with type 2 diabetes and chronic kidney diseaseBMC Nephrology, 2013
- Relationship of Plasma Galectin‐3 to Renal Function in Patients With Heart Failure: Effects of Clinical Status, Pathophysiology of Heart Failure, and Presence or Absence of Heart FailureJournal of the American Heart Association, 2012
- Tubular Atrophy and Interstitial Fibrosis After Renal Transplantation Is Dependent on Galectin-3Transplantation, 2012
- Galectin-8 in IgA Nephritis: Decreased Binding of IgA by Galectin-8 Affinity Chromatography and Associated Increased Binding in Non-IgA Serum GlycoproteinsJournal of Clinical Immunology, 2011
- Modified Citrus Pectin Reduces Galectin-3 Expression and Disease Severity in Experimental Acute Kidney InjuryPLOS ONE, 2011
- Modified citrus pectin anti-metastatic properties: one bullet, multiple targetsCarbohydrate Research, 2009
- A Role for galectin-3 in renal tissue damage triggered by ischemia and reperfusion injuryTransplant International, 2008
- Galectin-3 Expression and Secretion Links Macrophages to the Promotion of Renal FibrosisThe American Journal of Pathology, 2008
- Galectin‐3/AGE‐receptor 3 knockout mice show accelerated AGE‐induced glomerular injury: evidence for a protective role of galectin‐3 as an AGE receptorThe FASEB Journal, 2004
- Modulation of the Lung Colonization of B16-F1 Melanoma Cells by Citrus PectinJNCI Journal of the National Cancer Institute, 1992